Xiangao Huang
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 13
-
- Lymphoma Diagnosis and Treatment 10
- Hematology top 5%
- Multiple Myeloma Research and Treatments 18
- Oncology top 10%
- Cancer-related Molecular Pathways 10
-
- Advanced Breast Cancer Therapies 15
-
- Ubiquitin and proteasome pathways 10
- Protein Degradation and Inhibitors 10
-
- Microtubule and mitosis dynamics 4
- Co-authors
- Selina Chen‐KiangMaurizio Di LibertoScott ElyPeter MartinJohn P. LeonardChristopher E. MasonDavid ChironRubén Niesvizky
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Xiangao Huang
37 papers receiving 866 citations
Peers
Comparison fields: 5 of 60
- Genetics 325
- Pathology and Forensic Medicine 311
- Hematology 193
- Oncology 382
- Immunology 159
Countries citing papers authored by Xiangao Huang
This map shows the geographic impact of Xiangao Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangao Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangao Huang more than expected).
Fields of papers citing papers by Xiangao Huang
This network shows the impact of papers produced by Xiangao Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangao Huang. The network helps show where Xiangao Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiangao Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 19 | |
| 2 | 2023 | 0 | |
| 3 | 2021 | 9 | |
| 4 | 2021 | 0 | |
| 5 | 2020 | 7 | |
| 6 | 2020 | 6 | |
| 7 | 2020 | 11 | |
| 8 | 2016 | 3 | |
| 9 | 2015 | 47 | |
| 10 | 2015 | 6 | |
| 11 | 2015 | 5 | |
| 12 | 2014 | 204 | |
| 13 | 2013 | 59 | |
| 14 | 2013 | 5 | |
| 15 | 2012 | 75 | |
| 16 | 2011 | 79 | |
| 17 | 2010 | 1 | |
| 18 | 2009 | 5 | |
| 19 | 2008 | 3 | |
| 20 | 2004 | 6 |
About Xiangao Huang
Xiangao Huang is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 873 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Advanced Breast Cancer Therapies (15 papers), Chronic Lymphocytic Leukemia Research (13 papers), Ubiquitin and proteasome pathways (10 papers), Cancer-related Molecular Pathways (10 papers), Lymphoma Diagnosis and Treatment (10 papers), Protein Degradation and Inhibitors (10 papers) and Microtubule and mitosis dynamics (4 papers). The work is most often cited by research in Genetics (325 citations), Pathology and Forensic Medicine (311 citations), Hematology (193 citations), Oncology (382 citations) and Immunology (159 citations). Xiangao Huang has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Selina Chen‐Kiang, Maurizio Di Liberto, Scott Ely, Peter Martin, John P. Leonard, Christopher E. Mason, David Chiron, Rubén Niesvizky, Isan Chen and David Jayabalan. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer Research, Hematology/Oncology Clinics of North America and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.